Zhaowenxue (Talk | contribs) |
Zhaowenxue (Talk | contribs) |
||
Line 28: | Line 28: | ||
<div id="collapseOne" class="panel-collapse collapse"> | <div id="collapseOne" class="panel-collapse collapse"> | ||
<div class="panel-body"> | <div class="panel-body"> | ||
− | < | + | <h3 class="title">Team registration and brainstorm</h3> |
<p>During this time, we registrated the team SKLMT-China in iGEM. In order to verify the feasibility of our project, we discussed with professors and experts and did some human practice work.</p> | <p>During this time, we registrated the team SKLMT-China in iGEM. In order to verify the feasibility of our project, we discussed with professors and experts and did some human practice work.</p> | ||
</div> | </div> | ||
Line 44: | Line 44: | ||
<div id="collapseTwo" class="panel-collapse collapse"> | <div id="collapseTwo" class="panel-collapse collapse"> | ||
<div class="panel-body"> | <div class="panel-body"> | ||
− | < | + | <h3 class="title">Find promoters with various strength in the light of transcriptom references. Take the sequence from the upstream of a specific gene. </h3> |
<div class="table-wrapper"> | <div class="table-wrapper"> | ||
<table class="alt"> | <table class="alt"> | ||
Line 196: | Line 196: | ||
<tr> | <tr> | ||
<td>24</td> | <td>24</td> | ||
− | + | <td>Pdiv</td> | |
− | <td>GAGCTGACCCGGCGCACCCTCAAGCAAGGTCTGGAACTGCTGGGCCTCAAAGTCCTGGAGCAAATGTAAG</td> | + | <td>GAGCTGACCCGGCGCACCCTCAAGCAAGGTCTGGAACTGCTGGGCCTCAAAGTCCTGGAGCAAATGTAAG</td> |
<td>70</td> | <td>70</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>25</td> | <td>25</td> | ||
− | + | <td>Plip</td> | |
− | <td>AGGTTCTGATGTTTTCCGGGCAAGGCCTGAAGTAAAAAAACCGGGGCTTCGGGCCCACGGGAGAAAAATA</td> | + | <td>AGGTTCTGATGTTTTCCGGGCAAGGCCTGAAGTAAAAAAACCGGGGCTTCGGGCCCACGGGAGAAAAATA</td> |
<td>70</td> | <td>70</td> | ||
</tr> | </tr> | ||
Line 216: | Line 216: | ||
</div> | </div> | ||
</div> | </div> | ||
− | + | ||
+ | <div class="panel panel-default"> | ||
<div class="panel-heading"> | <div class="panel-heading"> | ||
<h4 class="panel-title"> | <h4 class="panel-title"> | ||
<a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | <a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | ||
− | + | week6 | |
</a> | </a> | ||
</h4> | </h4> | ||
Line 226: | Line 227: | ||
<div id="collapseTwo" class="panel-collapse collapse"> | <div id="collapseTwo" class="panel-collapse collapse"> | ||
<div class="panel-body"> | <div class="panel-body"> | ||
− | <p> | + | <p>design the PAGE-purified oligonucleotides used to amplify the chloramphenicol</p> |
+ | |||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div class="panel panel-default"> | ||
+ | <div class="panel-heading"> | ||
+ | <h4 class="panel-title"> | ||
+ | <a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | ||
+ | week7&8 | ||
+ | </a> | ||
+ | </h4> | ||
+ | </div> | ||
+ | <div id="collapseTwo" class="panel-collapse collapse"> | ||
+ | <div class="panel-body"> | ||
+ | <p>amplify the chloramphnicol and promoter segment and add vector homology arms via series PCR. Purify the PCR products using the TianGen PCR Purification Kit and elute into 30ul of autoclaved ddH2O. Quantify the elution using a NanoDrop UV spectrophotometer, store them at 4℃。</p> | ||
+ | <p>In order to obtain an artificial promoter library suitable for cloning, promoter sequence flanked by homology arms was added a chloramphenicol selection marker. This sequence was synthesized by sangon ®. </p> | ||
+ | <p>TABLE 2 Oligonucleotides used for PCR of the DNA segment containing the promoter and chloramphenicol selective marker </p> | ||
<div class="table-wrapper"> | <div class="table-wrapper"> | ||
<table class="alt"> | <table class="alt"> | ||
<thead> | <thead> | ||
<tr> | <tr> | ||
− | <th> | + | <th>Primer</th> |
− | + | ||
<th> Sequence 5'-3'</th> | <th> Sequence 5'-3'</th> | ||
− | <th> | + | <th>length</th> |
</tr> | </tr> | ||
</thead> | </thead> | ||
<tbody> | <tbody> | ||
<tr> | <tr> | ||
− | <td> | + | <td>Syn-primer 1</td> |
− | <td> | + | <td> AATGAATTACAACAGTTTTTATGCAGATATCAATTAATTTGGTTATGTGTGGGAGGGCTA </td> |
− | <td> | + | <td>60</td> |
− | + | ||
</tr> | </tr> | ||
− | + | <tr> | |
− | <td> | + | <td> ampC-2 </td> |
− | + | <td>TGGGTTCTGGTTATGTACGCCGCGTTTGTCCCAGCGGCTTTGCGGCCCCGGCGTATTAATGACGTTGATCGGCACGTAAG</td> | |
− | <td> | + | <td>80</td> |
− | <td> | + | |
</tr> | </tr> | ||
− | + | <tr> | |
− | <td> | + | <td>araA-2 </td> |
− | + | <td>AGACAAAACAATCGGGGGTGTTGCTAGAGCTATAGGGTCAGGAAGCCGTCGTAGATTAATGACGTTGATCGGCACGTAAG</td> | |
− | <td> | + | <td>80</td> |
− | <td> | + | |
</tr> | </tr> | ||
− | + | <tr> | |
− | <td> | + | <td>fabD-2 </td> |
− | + | <td>GATCTTGTCGTCGGAGAATTGACGTCACACCGTGGTGGACGCAAGAAACTGACAATTAATGACGTTGATCGGCACGTAAG</td> | |
− | <td> | + | <td>80</td> |
− | <td> | + | |
</tr> | </tr> | ||
− | + | <tr> | |
− | <td> | + | <td>ccmD-2 </td> |
− | + | <td>TGCGTTGGACTTCGGCCTTGACCCAACTGGTCCGGGCTTCACGCTTGAGCACCTATTAATGACGTTGATCGGCACGTAAG</td> | |
− | <td> | + | <td>80</td> |
− | <td> | + | |
</tr> | </tr> | ||
− | + | <tr> | |
− | <td> | + | <td> fliA-2 </td> |
− | + | <td>TTTGATGCACTAGCCGCTCGACAAAAAACTCCAGATGCCCGCGTGGGTTCGCCGATTAATGACGTTGATCGGCACGTAAG</td> | |
− | <td> | + | <td>80</td> |
− | <td> | + | |
</tr> | </tr> | ||
− | + | <tr> | |
− | <td> | + | <td> pltR-2 </td> |
− | + | <td>AATTTTTAGTGTCTTATTTTTGTAAAGGCAAATTACAAATAGATCATGACAGCCATTAATGACGTTGATCGGCACGTAAG</td> | |
− | <td> | + | <td>80</td> |
− | <td> | + | |
</tr> | </tr> | ||
− | + | <tr> | |
− | <td> | + | <td> proC-2 </td> |
− | + | <td>AGGTCGGGGTCAGTCGCATCAGGACTGACTGTAGTCGCGGGCACCAAACAGCGCATTAATGACGTTGATCGGCACGTAAG</td> | |
− | <td> | + | <td>80</td> |
− | <td> | + | |
</tr> | </tr> | ||
+ | <tr> | ||
+ | <td> recA-2 </td> | ||
+ | <td>TCAATAAGGCCTGACGGCCAACACCTGTATAAGTAGCCAGTATTATTCCACAGCATTAATGACGTTGATCGGCACGTAAG</td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> rpoD-2 </td> | ||
+ | <td>AAGGTCTTGGCGGGCAAAAAACAAGCCGAGGATTATACCCGAGCTATGACCTCAATTAATGACGTTGATCGGCACGTAAG</td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> rpoS-2 </td> | ||
+ | <td>TGAGTTCGACCTCAGGCTCAAGCGGCGCCTTTATCCCTGGCAACGCTGGAGCCTATTAATGACGTTGATCGGCACGTAAG</td> | ||
+ | <td>8f0</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> dnaA-2 </td> | ||
+ | <td>GAAAGCCGGTGAGGCAAAAACAAGCGGCCATTGTAGCGATCAGCCGCCCACTTAATTAATGACGTTGATCGGCACGTAAG</td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> pol-2 </td> | ||
+ | <td>TTCGGCGGGTCCGGCGCTAGAATAGCGGGACCGTTGACGACAAAGGGACAAGGtATTAATGACGTTGATCGGCACGTAAG</td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> 16s-2 </td> | ||
+ | <td>TGAGAAAACCCTAAACTTGGCTCAGCAATCGTTGGTTACATCTTTGATTTCTCGATTAATGACGTTGATCGGCACGTAAG</td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>sig-2 </td> | ||
+ | <td>AGTGTCACTAATGATAATTAGTCGCATTGTCATTGAGGCTTTATCGATTTGGCAATTAATGACGTTGATCGGCACGTAAG</td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>atf-2 </td> | ||
+ | <td>CGGGCGGCCGGACAATCGGGCCGCGCAAACGGCGATCACTTTACGCCCGGCGACATTAATGACGTTGATCGGCACGTAAG</td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>fme-2 </td> | ||
+ | <td>AAACATGCGGAAAAGAAAAAGGCTTGCCGTAGCAAGCCTTTGCAAGACGGTCATATTAATGACGTTGATCGGCACGTAAG </td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>mem-2 </td> | ||
+ | <td>AAGATGCGGCGAATGATAGCGGGGCGGGCAGAAACGACAAACCCCGGATTAACCATTAATGACGTTGATCGGCACGTAAG</td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>fat-2 </td> | ||
+ | <td>CAGTGATGTGTGCATCCTGCCCCGAGCCCCGGCTCCGGGCGCTAGCCGTAAACGATTAATGACGTTGATCGGCACGTAAG</td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>ami-2 </td> | ||
+ | <td>TTGTTATAGGGCGCTTATATCGCCACTGCGCAAGTTAATGCGCAACCCCAAACCATTAATGACGTTGATCGGCACGTAAG </td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>rib-2 </td> | ||
+ | <td>TAGCGTGCCGCCACCCAACACTATTGTTGAATACCGCACGAATTAGGGCGCGAAATTAATGACGTTGATCGGCACGTAAG </td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>abc-2 </td> | ||
+ | <td>AAGTCGCCCGACCCCGGGCGCCTGCCGGCCTGGGCCGGCAATTTTATTTGCGGGATTAATGACGTTGATCGGCACGTAAG </td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>edo-2 </td> | ||
+ | <td>TTGGCTGCGCGCTCTTTGGCGATCAACTGGTCAGCCACGCTCAGCGCGCCTTCAATTAATGACGTTGATCGGCACGTAAG</td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>tox-2 </td> | ||
+ | <td>GCTGCTTGTGGTTAGCGGGTCTTGGGTGTTAGAGCACTCAAGGCCCGCGTCTTTATTAATGACGTTGATCGGCACGTAAG </td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>div-2 </td> | ||
+ | <td>GACTTTGAGGCCCAGCAGTTCCAGACCTTGCTTGAGGGTGCGCCGGGTCAGCTCATTAATGACGTTGATCGGCACGTAAG </td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>lip-2 </td> | ||
+ | <td>GCCCGAAGCCCCGGTTTTTTTACTTCAGGCCTTGCCCGGAAAACATCAGAACCTATTAATGACGTTGATCGGCACGTAAG </td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | |||
+ | </tbody> | ||
+ | |||
+ | </table> | ||
+ | </div> | ||
+ | <h5 class="title">Set up the PCR reaction using pR6K-cm-ccdB as a template. Typically, set up the PCR reaction (50ul in total) to obtain sufficient amounts of DNA.</h5> | ||
+ | <div class="table-wrapper"> | ||
+ | <table class="alt"> | ||
+ | <thead> | ||
<tr> | <tr> | ||
− | < | + | <th>Component</th> |
− | + | <th>Amount(ul)</th> | |
− | < | + | <th>Final</th> |
− | < | + | |
</tr> | </tr> | ||
+ | </thead> | ||
+ | <tbody> | ||
<tr> | <tr> | ||
− | <td> | + | <td>Autoclaved ddH2O</td> |
− | + | <td>22</td> | |
− | <td> | + | <td></td> |
− | <td> | + | |
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td> | + | <td>2×primeSTAR max premix</td> |
− | + | <td>25</td> | |
− | <td> | + | <td>1×</td> |
− | <td> | + | |
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td> | + | <td>Template, 50ng ul<sub>-1</sub></td> |
− | + | <td>1</td> | |
− | <td> | + | <td>50 ng</td> |
− | <td> | + | |
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td> | + | <td>Syn-promoter-1 Oligo(10uM)</td> |
− | + | <td>1</td> | |
− | <td> | + | <td>30 pmol</td> |
− | <td> | + | |
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td> | + | <td>promoter-2 Oligo(10uM)</td> |
− | + | <td>1</td> | |
− | <td> | + | <td>30 pmol</td> |
− | <td> | + | |
</tr> | </tr> | ||
+ | </tbody> | ||
+ | <tfoot> | ||
<tr> | <tr> | ||
− | <td> | + | <td>Total</td> |
− | + | <td>50</td> | |
− | + | ||
− | <td> | + | |
</tr> | </tr> | ||
+ | </tfoot> | ||
+ | </table> | ||
+ | </div> | ||
+ | <p>Carry out the PCR in a thermal cycle following the instructions below:</p> | ||
+ | <div class="table-wrapper"> | ||
+ | <table class="alt"> | ||
+ | <thead> | ||
<tr> | <tr> | ||
− | < | + | <th>Cycle number</th> |
− | + | <th> Denaturation </th> | |
− | < | + | <th> Annealing </th> |
− | + | <th> Termination </th> | |
</tr> | </tr> | ||
+ | </thead> | ||
+ | <tbody> | ||
<tr> | <tr> | ||
− | <td> | + | <td>1</td> |
− | + | <td>94℃,4min </td> | |
− | <td> | + | <td></td> |
− | + | <td></td> | |
+ | <td></td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td> | + | <td>2~31</td> |
− | + | <td>98℃, 15s </td> | |
− | + | <td>59℃, 15s</td> | |
− | <td> | + | <td>72℃, 15s </td> |
+ | <td></td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td> | + | <td>32</td> |
− | + | <td></td> | |
− | <td> | + | <td> </td> |
− | <td> | + | <td>72℃, 4min</td> |
+ | <td></td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td> | + | <td>33</td> |
− | + | <td></td> | |
− | <td> | + | <td></td> |
− | + | <td></td> | |
+ | <td>10℃, hold </td> | ||
</tr> | </tr> | ||
+ | |||
+ | </tbody> | ||
+ | |||
+ | </table> | ||
+ | </div> | ||
+ | <p>Add vector homology arms to the PCR products purified</p> | ||
+ | <p>Using the purified PCR products from last step as a template. Use the PAGE-purified oligonucleotides ,Syn-promoter-3 and promoter-4 (Table3), to amplify the cm-promoter. </p> | ||
+ | <p>TABLE 3 Oligonucleotides used for PCR of the DNA segment containing the promoter and chloramphenicol selective marker</p> | ||
+ | <div class="table-wrapper"> | ||
+ | <table class="alt"> | ||
+ | <thead> | ||
<tr> | <tr> | ||
− | < | + | <th>Primer</th> |
− | + | <th> Sequence 5'-3'</th> | |
− | < | + | <th>length</th> |
− | + | ||
</tr> | </tr> | ||
+ | </thead> | ||
+ | <tbody> | ||
<tr> | <tr> | ||
+ | <td>Syn-primer 3</td> | ||
+ | <td> AATGAATTACAACAGTTTTTAT</td> | ||
<td>22</td> | <td>22</td> | ||
− | |||
− | |||
− | |||
</tr> | </tr> | ||
− | + | <tr> | |
− | <td> | + | <td> ampC-4 </td> |
− | + | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATGATTGGTTGGTTTCCCTGGGTTCTGGTTATGTACGC </td> | |
− | <td> | + | <td>76</td> |
− | <td> | + | |
</tr> | </tr> | ||
− | + | <tr> | |
− | <td> | + | <td>araA-4 </td> |
− | + | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATTACTGTGATCCTCCAGAGACAAAACAATCGGGGGTG</td> | |
− | + | <td>76</td> | |
− | <td> | + | |
− | <td> | + | |
</tr> | </tr> | ||
− | + | <tr> | |
− | <td> | + | <td>fabD-4 </td> |
− | + | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATGTAACAAGCCCCTAATGATCTTGTCGTCGGAGAATT</td> | |
− | <td> | + | <td>76</td> |
− | <td> | + | |
</tr> | </tr> | ||
+ | <tr> | ||
+ | <td>ccmD-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATCGGGCGGCCTCCAGGCTGCGTTGGACTTCGGCCTTGA</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> fliA-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATAGCACCGGTCCCGCTGTTTGATGCACTAGCCGCTCG</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> pltR-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATTCCTAAATCCTTTTAGAATTTTTAGTGTCTTATTTT</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> proC-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATGACAGGTCCTTACAAGAGGTCGGGGTCAGTCGCATC</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> recA-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATTAAAGTCCTCACGTAATCAATAAGGCCTGACGGCCA</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> rpoD-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATAACACCCTATCCACTGAAGGTCTTGGCGGGCAAAAA</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> rpoS-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATTGTTATAGTCCTTTGGTGAGTTCGACCTCAGGCTCA</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> dnaA-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATggatatcccctaagttgaaagccggtgaggcaaaaa</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> pol-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATgagcgggatcaaccttttcggcgggtccggcgctag</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td> 16s-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATaaacatctttgggttttgagaaaaccctaaacttgg</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>sig-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATggacgcggactgcctgagtgtcactaatgataatta</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>atf-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATgataagactccttactcgggcggccggacaatcggg</td> | ||
+ | <td>80</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>fme-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATgggaattctcgatgttaaacatgcggaaaagaaaaa</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>mem-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATcggtcatacccctcgaaagatgcggcgaatgatagc</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>fat-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATgattccatcctctggtcagtgatgtgtgcatcctgc</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>ami-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATacaacgacccctggaattgttatagggcgcttatat</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>rib-4</td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATggtgtattcctcaggctagcgtgccgccacccaaca</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>abc-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATccaacaagctccttgtaagtcgcccgaccccgggcg</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>edo-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATggcggcgggcgcttacttggctgcgcgctctttggc</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>tox-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATattcagctcctgtttagctgcttgtggttagcgggt </td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>div-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATcttacatttgctccaggactttgaggcccagcagtt</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>lip-4 </td> | ||
+ | <td>ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATtatttttctcccgtgggcccgaagccccggtttttt</td> | ||
+ | <td>76</td> | ||
+ | </tr> | ||
+ | |||
</tbody> | </tbody> | ||
</table> | </table> | ||
</div> | </div> | ||
− | + | <p>Using the purified PCR products from step2 as a template. set up the PCR reaction (50ul in total) to obtain sufficient amounts of DNA</p> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | <p> | + | |
− | + | ||
− | + | ||
− | + | ||
<div class="table-wrapper"> | <div class="table-wrapper"> | ||
<table class="alt"> | <table class="alt"> | ||
Line 439: | Line 656: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td>Syn-promoter- | + | <td>Syn-promoter-3 Oligo(10uM)</td> |
<td>1</td> | <td>1</td> | ||
<td>30 pmol</td> | <td>30 pmol</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td>promoter- | + | <td>promoter-4 Oligo(10uM)</td> |
<td>1</td> | <td>1</td> | ||
<td>30 pmol</td> | <td>30 pmol</td> | ||
Line 479: | Line 696: | ||
<td>2~31</td> | <td>2~31</td> | ||
<td>98℃, 15s </td> | <td>98℃, 15s </td> | ||
− | <td>59℃, 15s</td> | + | <td>52~59℃, 15s, 15s </td> |
<td>72℃, 15s </td> | <td>72℃, 15s </td> | ||
<td></td> | <td></td> | ||
Line 502: | Line 719: | ||
</table> | </table> | ||
</div> | </div> | ||
− | < | + | <p>Purify the PCR products using the TianGen PCR Purification Kit and elute into 30ul of autoclaved ddH2O. Quantify the elution using a NanoDrop UV spectrophotometer.</p> |
− | + | <img src="T--SKLMT-China--promoter11-15.png" width="400" height="400"/> | |
</div> | </div> | ||
</div> | </div> | ||
Line 511: | Line 728: | ||
<h4 class="panel-title"> | <h4 class="panel-title"> | ||
<a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | <a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | ||
− | + | week9 | |
</a> | </a> | ||
</h4> | </h4> | ||
Line 526: | Line 743: | ||
<h4 class="panel-title"> | <h4 class="panel-title"> | ||
<a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | <a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | ||
− | + | week10 | |
</a> | </a> | ||
</h4> | </h4> | ||
Line 541: | Line 758: | ||
<h4 class="panel-title"> | <h4 class="panel-title"> | ||
<a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | <a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | ||
− | + | week11 | |
</a> | </a> | ||
</h4> | </h4> | ||
Line 555: | Line 772: | ||
<h4 class="panel-title"> | <h4 class="panel-title"> | ||
<a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | <a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | ||
− | + | week12 | |
</a> | </a> | ||
</h4> | </h4> | ||
Line 570: | Line 787: | ||
<h4 class="panel-title"> | <h4 class="panel-title"> | ||
<a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | <a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | ||
− | + | week13 | |
</a> | </a> | ||
</h4> | </h4> | ||
Line 585: | Line 802: | ||
<h4 class="panel-title"> | <h4 class="panel-title"> | ||
<a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | <a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | ||
− | + | week14 | |
</a> | </a> | ||
</h4> | </h4> | ||
Line 599: | Line 816: | ||
<h4 class="panel-title"> | <h4 class="panel-title"> | ||
<a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | <a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | ||
− | + | week15 | |
</a> | </a> | ||
</h4> | </h4> | ||
Line 613: | Line 830: | ||
<h4 class="panel-title"> | <h4 class="panel-title"> | ||
<a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | <a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | ||
− | + | week16 | |
</a> | </a> | ||
</h4> | </h4> | ||
Line 627: | Line 844: | ||
<h4 class="panel-title"> | <h4 class="panel-title"> | ||
<a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | <a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | ||
− | + | week17 | |
</a> | </a> | ||
</h4> | </h4> | ||
Line 641: | Line 858: | ||
<h4 class="panel-title"> | <h4 class="panel-title"> | ||
<a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | <a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | ||
− | + | week18 | |
</a> | </a> | ||
</h4> | </h4> | ||
Line 655: | Line 872: | ||
<h4 class="panel-title"> | <h4 class="panel-title"> | ||
<a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | <a data-toggle="collapse" data-parent="#accordion" href="#collapseTwo"> | ||
− | + | week19 | |
</a> | </a> | ||
</h4> | </h4> |
Revision as of 12:11, 15 October 2018
Team registration and brainstorm
During this time, we registrated the team SKLMT-China in iGEM. In order to verify the feasibility of our project, we discussed with professors and experts and did some human practice work.
Find promoters with various strength in the light of transcriptom references. Take the sequence from the upstream of a specific gene.
Number | Promoter | Sequence 5'-3' | Length |
---|---|---|---|
01 | PampC | ACGCCGGGGCCGCAAAGCCGCTGGGACAAACGCGGCGTACATAACCAGAACCCAGGGAAACCAACCAATC | 70 |
02 | ParaA | CTACGACGGCTTCCTGACCCTATAGCTCTAGCAACACCCCCGATTGTTTTGTCTCTGGAGGATCACAGTA | 70 |
03 | PfabD | TGTCAGTTTCTTGCGTCCACCACGGTGTGACGTCAATTCTCCGACGACAAGATCATTAGGGGCTTGTTAC | 70 |
04 | PccmD | AGGTGCTCAAGCGTGAAGCCCGGACCAGTTGGGTCAAGGCCGAAGTCCAACGCAGCCTGGAGGCCGCCCG | 70 |
05 | PfliA | CGGCGAACCCACGCGGGCATCTGGAGTTTTTTGTCGAGCGGCTAGTGCATCAAACAGCGGGACCGGTGCT | 70 |
06 | PltR | GGCTGTCATGATCTATTTGTAATTTGCCTTTACAAAAATAAGACACTAAAAATTCTAAAAGGATTTAGGA | 70 |
07 | PproC | GCGCTGTTTGGTGCCCGCGACTACAGTCAGTCCTGATGCGACTGACCCCGACCTCTTGTAAGGACCTGTC | 70 |
08 | PrecA | GCTGTGGAATAATACTGGCTACTTATACAGGTGTTGGCCGTCAGGCCTTATTGATTACGTGAGGACTTTA | 70 |
09 | PrpoD | TGAGGTCATAGCTCGGGTATAATCCTCGGCTTGTTTTTTGCCCGCCAAGACCTTCAGTGGATAGGGTGTT | 70 |
10 | PrpoS | AGGCTCCAGCGTTGCCAGGGATAAAGGCGCCGCTTGAGCCTGAGGTCGAACTCACCAAAGGACTATAACA | 70 |
11 | PdnaA | TAAGTGGGCGGCTGATCGCTACAATGGCCGCTTGTTTTTGCCTCACCGGCTTTCAACTTAGGGGATATCC | 70 |
12 | Ppol | ACCTTGTCCCTTTGTCGTCAACGGTCCCGCTATTCTAGCGCCGGACCCGCCGAAAAGGTTGATCCCGCTC | 70 |
13 | P16s | CGAGAAATCAAAGATGTAACCAACGATTGCTGAGCCAAGTTTAGGGTTTTCTCAAAACCCAAAGATGTTT | 70 |
14 | Psig | TGCCAAATCGATAAAGCCTCAATGACAATGCGACTAATTATCATTAGTGACACTCAGGCAGTCCGCGTCC | 70 |
15 | Patf | GTCGCCGGGCGTAAAGTGATCGCCGTTTGCGCGGCCCGATTGTCCGGCCGCCCGAGTAAGGAGTCTTATC | 70 |
16 | Pfme | ATGACCGTCTTGCAAAGGCTTGCTACGGCAAGCCTTTTTCTTTTCCGCATGTTTAACATCGAGAATTCCC | 70 |
17 | Pmem | GGTTAATCCGGGGTTTGTCGTTTCTGCCCGCCCCGCTATCATTCGCCGCATCTTTCGAGGGGTATGACCG | 70 |
18 | Pfat | CGTTTACGGCTAGCGCCCGGAGCCGGGGCTCGGGGCAGGATGCACACATCACTGACCAGAGGATGGAATC | 70 |
19 | Pami | GGTTTGGGGTTGCGCACTAACTTGCGCAGTGGCGATATAAGCGCCCTATAACAATTCCAGGGGTCGTTGT | 70 |
20 | Prib | TTCGCGCCCTAATTCGTGCGGTATTCAACAATAGTGTTGGGTGGCGGCACGCTAGCCTGAGGAATACACC | 70 |
21 | Pabc | CCCGCAAATAAAATTGCCGGCCCAGGCCGGCAGGCGCCCGGGGTCGGGCGACTTACAAGGAGCTTGTTGG | 70 |
22 | Pedo | TGAAGGCGCGCTGAGCGTGGCTGACCAGTTGATCGCCAAAGAGCGCGCAGCCAAGTAAGCGCCCGCCGCC | 70 |
23 | Ptox | AAAGACGCGGGCCTTGAGTGCTCTAACACCCAAGACCCGCTAACCACAAGCAGCTAAACAGGAGCTGAAT | 70 |
24 | Pdiv | GAGCTGACCCGGCGCACCCTCAAGCAAGGTCTGGAACTGCTGGGCCTCAAAGTCCTGGAGCAAATGTAAG | 70 |
25 | Plip | AGGTTCTGATGTTTTCCGGGCAAGGCCTGAAGTAAAAAAACCGGGGCTTCGGGCCCACGGGAGAAAAATA | 70 |
design the PAGE-purified oligonucleotides used to amplify the chloramphenicol
amplify the chloramphnicol and promoter segment and add vector homology arms via series PCR. Purify the PCR products using the TianGen PCR Purification Kit and elute into 30ul of autoclaved ddH2O. Quantify the elution using a NanoDrop UV spectrophotometer, store them at 4℃。
In order to obtain an artificial promoter library suitable for cloning, promoter sequence flanked by homology arms was added a chloramphenicol selection marker. This sequence was synthesized by sangon ®.
TABLE 2 Oligonucleotides used for PCR of the DNA segment containing the promoter and chloramphenicol selective marker
Primer | Sequence 5'-3' | length |
---|---|---|
Syn-primer 1 | AATGAATTACAACAGTTTTTATGCAGATATCAATTAATTTGGTTATGTGTGGGAGGGCTA | 60 |
ampC-2 | TGGGTTCTGGTTATGTACGCCGCGTTTGTCCCAGCGGCTTTGCGGCCCCGGCGTATTAATGACGTTGATCGGCACGTAAG | 80 |
araA-2 | AGACAAAACAATCGGGGGTGTTGCTAGAGCTATAGGGTCAGGAAGCCGTCGTAGATTAATGACGTTGATCGGCACGTAAG | 80 |
fabD-2 | GATCTTGTCGTCGGAGAATTGACGTCACACCGTGGTGGACGCAAGAAACTGACAATTAATGACGTTGATCGGCACGTAAG | 80 |
ccmD-2 | TGCGTTGGACTTCGGCCTTGACCCAACTGGTCCGGGCTTCACGCTTGAGCACCTATTAATGACGTTGATCGGCACGTAAG | 80 |
fliA-2 | TTTGATGCACTAGCCGCTCGACAAAAAACTCCAGATGCCCGCGTGGGTTCGCCGATTAATGACGTTGATCGGCACGTAAG | 80 |
pltR-2 | AATTTTTAGTGTCTTATTTTTGTAAAGGCAAATTACAAATAGATCATGACAGCCATTAATGACGTTGATCGGCACGTAAG | 80 |
proC-2 | AGGTCGGGGTCAGTCGCATCAGGACTGACTGTAGTCGCGGGCACCAAACAGCGCATTAATGACGTTGATCGGCACGTAAG | 80 |
recA-2 | TCAATAAGGCCTGACGGCCAACACCTGTATAAGTAGCCAGTATTATTCCACAGCATTAATGACGTTGATCGGCACGTAAG | 80 |
rpoD-2 | AAGGTCTTGGCGGGCAAAAAACAAGCCGAGGATTATACCCGAGCTATGACCTCAATTAATGACGTTGATCGGCACGTAAG | 80 |
rpoS-2 | TGAGTTCGACCTCAGGCTCAAGCGGCGCCTTTATCCCTGGCAACGCTGGAGCCTATTAATGACGTTGATCGGCACGTAAG | 8f0 |
dnaA-2 | GAAAGCCGGTGAGGCAAAAACAAGCGGCCATTGTAGCGATCAGCCGCCCACTTAATTAATGACGTTGATCGGCACGTAAG | 80 |
pol-2 | TTCGGCGGGTCCGGCGCTAGAATAGCGGGACCGTTGACGACAAAGGGACAAGGtATTAATGACGTTGATCGGCACGTAAG | 80 |
16s-2 | TGAGAAAACCCTAAACTTGGCTCAGCAATCGTTGGTTACATCTTTGATTTCTCGATTAATGACGTTGATCGGCACGTAAG | 80 |
sig-2 | AGTGTCACTAATGATAATTAGTCGCATTGTCATTGAGGCTTTATCGATTTGGCAATTAATGACGTTGATCGGCACGTAAG | 80 |
atf-2 | CGGGCGGCCGGACAATCGGGCCGCGCAAACGGCGATCACTTTACGCCCGGCGACATTAATGACGTTGATCGGCACGTAAG | 80 |
fme-2 | AAACATGCGGAAAAGAAAAAGGCTTGCCGTAGCAAGCCTTTGCAAGACGGTCATATTAATGACGTTGATCGGCACGTAAG | 80 |
mem-2 | AAGATGCGGCGAATGATAGCGGGGCGGGCAGAAACGACAAACCCCGGATTAACCATTAATGACGTTGATCGGCACGTAAG | 80 |
fat-2 | CAGTGATGTGTGCATCCTGCCCCGAGCCCCGGCTCCGGGCGCTAGCCGTAAACGATTAATGACGTTGATCGGCACGTAAG | 80 |
ami-2 | TTGTTATAGGGCGCTTATATCGCCACTGCGCAAGTTAATGCGCAACCCCAAACCATTAATGACGTTGATCGGCACGTAAG | 80 |
rib-2 | TAGCGTGCCGCCACCCAACACTATTGTTGAATACCGCACGAATTAGGGCGCGAAATTAATGACGTTGATCGGCACGTAAG | 80 |
abc-2 | AAGTCGCCCGACCCCGGGCGCCTGCCGGCCTGGGCCGGCAATTTTATTTGCGGGATTAATGACGTTGATCGGCACGTAAG | 80 |
edo-2 | TTGGCTGCGCGCTCTTTGGCGATCAACTGGTCAGCCACGCTCAGCGCGCCTTCAATTAATGACGTTGATCGGCACGTAAG | 80 |
tox-2 | GCTGCTTGTGGTTAGCGGGTCTTGGGTGTTAGAGCACTCAAGGCCCGCGTCTTTATTAATGACGTTGATCGGCACGTAAG | 80 |
div-2 | GACTTTGAGGCCCAGCAGTTCCAGACCTTGCTTGAGGGTGCGCCGGGTCAGCTCATTAATGACGTTGATCGGCACGTAAG | 80 |
lip-2 | GCCCGAAGCCCCGGTTTTTTTACTTCAGGCCTTGCCCGGAAAACATCAGAACCTATTAATGACGTTGATCGGCACGTAAG | 80 |
Set up the PCR reaction using pR6K-cm-ccdB as a template. Typically, set up the PCR reaction (50ul in total) to obtain sufficient amounts of DNA.
Component | Amount(ul) | Final |
---|---|---|
Autoclaved ddH2O | 22 | |
2×primeSTAR max premix | 25 | 1× |
Template, 50ng ul-1 | 1 | 50 ng |
Syn-promoter-1 Oligo(10uM) | 1 | 30 pmol |
promoter-2 Oligo(10uM) | 1 | 30 pmol |
Total | 50 |
Carry out the PCR in a thermal cycle following the instructions below:
Cycle number | Denaturation | Annealing | Termination | |
---|---|---|---|---|
1 | 94℃,4min | |||
2~31 | 98℃, 15s | 59℃, 15s | 72℃, 15s | |
32 | 72℃, 4min | |||
33 | 10℃, hold |
Add vector homology arms to the PCR products purified
Using the purified PCR products from last step as a template. Use the PAGE-purified oligonucleotides ,Syn-promoter-3 and promoter-4 (Table3), to amplify the cm-promoter.
TABLE 3 Oligonucleotides used for PCR of the DNA segment containing the promoter and chloramphenicol selective marker
Primer | Sequence 5'-3' | length |
---|---|---|
Syn-primer 3 | AATGAATTACAACAGTTTTTAT | 22 |
ampC-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATGATTGGTTGGTTTCCCTGGGTTCTGGTTATGTACGC | 76 |
araA-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATTACTGTGATCCTCCAGAGACAAAACAATCGGGGGTG | 76 |
fabD-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATGTAACAAGCCCCTAATGATCTTGTCGTCGGAGAATT | 76 |
ccmD-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATCGGGCGGCCTCCAGGCTGCGTTGGACTTCGGCCTTGA | 76 |
fliA-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATAGCACCGGTCCCGCTGTTTGATGCACTAGCCGCTCG | 76 |
pltR-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATTCCTAAATCCTTTTAGAATTTTTAGTGTCTTATTTT | 76 |
proC-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATGACAGGTCCTTACAAGAGGTCGGGGTCAGTCGCATC | 76 |
recA-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATTAAAGTCCTCACGTAATCAATAAGGCCTGACGGCCA | 76 |
rpoD-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATAACACCCTATCCACTGAAGGTCTTGGCGGGCAAAAA | 76 |
rpoS-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATTGTTATAGTCCTTTGGTGAGTTCGACCTCAGGCTCA | 76 |
dnaA-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATggatatcccctaagttgaaagccggtgaggcaaaaa | 76 |
pol-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATgagcgggatcaaccttttcggcgggtccggcgctag | 76 |
16s-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATaaacatctttgggttttgagaaaaccctaaacttgg | 76 |
sig-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATggacgcggactgcctgagtgtcactaatgataatta | 76 |
atf-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATgataagactccttactcgggcggccggacaatcggg | 80 |
fme-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATgggaattctcgatgttaaacatgcggaaaagaaaaa | 76 |
mem-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATcggtcatacccctcgaaagatgcggcgaatgatagc | 76 |
fat-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATgattccatcctctggtcagtgatgtgtgcatcctgc | 76 |
ami-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATacaacgacccctggaattgttatagggcgcttatat | 76 |
rib-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATggtgtattcctcaggctagcgtgccgccacccaaca | 76 |
abc-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATccaacaagctccttgtaagtcgcccgaccccgggcg | 76 |
edo-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATggcggcgggcgcttacttggctgcgcgctctttggc | 76 |
tox-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATattcagctcctgtttagctgcttgtggttagcgggt | 76 |
div-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATcttacatttgctccaggactttgaggcccagcagtt | 76 |
lip-4 | ATGGCGCCGGGCCTTTCTTTATGTTTTTGGCGTCTTCCATtatttttctcccgtgggcccgaagccccggtttttt | 76 |
Using the purified PCR products from step2 as a template. set up the PCR reaction (50ul in total) to obtain sufficient amounts of DNA
Component | Amount(ul) | Final |
---|---|---|
Autoclaved ddH2O | 22 | |
2×primeSTAR max premix | 25 | 1× |
Template, 50ng ul-1 | 1 | 50 ng |
Syn-promoter-3 Oligo(10uM) | 1 | 30 pmol |
promoter-4 Oligo(10uM) | 1 | 30 pmol |
Total | 50 |
Carry out the PCR in a thermal cycle following the instructions below:
Cycle number | Denaturation | Annealing | Termination | |
---|---|---|---|---|
1 | 94℃,4min | |||
2~31 | 98℃, 15s | 52~59℃, 15s, 15s | 72℃, 15s | |
32 | 72℃, 4min | |||
33 | 10℃, hold |
Purify the PCR products using the TianGen PCR Purification Kit and elute into 30ul of autoclaved ddH2O. Quantify the elution using a NanoDrop UV spectrophotometer.
transform the plasmid pBBR1-kan-amp-ccdb-BAD-GFP-firefly into GB05 red gyrA462 via electroporation. Do Mini-Prep and screen correct plasmid by restriction analysis
construct the plasmid pBBR1-kan-cm-promoter(1-25)-firefly via liner circular recombination in GB05 red gyrA462. Do Mini-Prep and screen correct recombinants by restriction analysis.
transform the plasmid pBBR1-kan-amp-ccdb-BAD-GFP-firefly into p.fluorescence pf-5 via electroporation.
Chracterize the strength of different promoters by luciferase firefly assay.
Colleborate with seven Chinese iGEM teams to characterize the promoter strength under differdent conditions.
modeling
constract our software tool